nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Primer in Prognostic and Predictive Models: Development and Validation of Neutropenia Risk Models
|
Lyman, Gary H. |
|
2005 |
2 |
3 |
p. 168-175 8 p. |
artikel |
2 |
Chemotherapy-Induced Emesis: Quality of Life and Economic Impact in the Context of Current Practice in Canada
|
Lachaine, Jean |
|
2005 |
2 |
3 |
p. 181-187 7 p. |
artikel |
3 |
Highlights from: Third Annual Future of Supportive Therapy in Oncology, San Francisco, CA, February 2005; 27th Annual San Antonio Breast Cancer Symposium, San Antonio, TX, December 2004; 46th Annual Meeting of the American Society of Hematology, San Diego, CA December 2004
|
Reddy, G. Kesava |
|
2005 |
2 |
3 |
p. 143-148 6 p. |
artikel |
4 |
Impact of Erythropoietic Agents on Survival of Anemic Patients with Cancer
|
Reddy, G. Kesava |
|
2005 |
2 |
3 |
p. 156-158 3 p. |
artikel |
5 |
Improving Clinical Practice: The Importance of Guideline Development
|
Crawford, Jeffrey |
|
2005 |
2 |
3 |
p. 135-136 2 p. |
artikel |
6 |
Novel Thrombopoetin Mimetic Agents with Potential to Ameliorate Chemotherapy-Induced Thrombocytopenia
|
Tyagi, Preeta |
|
2005 |
2 |
3 |
p. 153-155 3 p. |
artikel |
7 |
Optimizing Management of Tumor Lysis Syndrome in Adults with Hematologic Malignancies
|
Michallet, Anne-Sophie |
|
2005 |
2 |
3 |
p. 159-166 8 p. |
artikel |
8 |
Patient Selection and Treatment of Tumor Lysis Syndrome in Adults with Hematologic Malignancies
|
Goldman, Stanton C. |
|
2005 |
2 |
3 |
p. 167- 1 p. |
artikel |
9 |
Pegfilgrastim: Recent Advances in the Prophylaxis of Chemotherapy-Induced Neutropenia
|
Reddy, G. Kesava |
|
2005 |
2 |
3 |
p. 149-152 4 p. |
artikel |
10 |
The Role of Methadone in the Treatment of Moderate to Severe Cancer Pain
|
Shaiova, Lauren |
|
2005 |
2 |
3 |
p. 176-180 5 p. |
artikel |
11 |
Tumor Lysis Syndrome in Solid Tumors
|
Mott, Frank E. |
|
2005 |
2 |
3 |
p. 188-191 4 p. |
artikel |